The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALCENTRA CAP CORP | COM | 01374T102 | 7,029 | 838,840 | SH | SOLE | 838,840 | 0 | 0 | ||
ALPS ETF TR | ALERIAN MLP | 00162Q866 | 4,528 | 459,744 | SH | SOLE | 459,744 | 0 | 0 | ||
AMERICAN TOWER CORP NEW | COM | 03027X100 | 232 | 1,136 | SH | SOLE | 1,136 | 0 | 0 | ||
BERKSHIRE HATHAWAY INC DEL | CL B NEW | 084670702 | 1,985 | 9,312 | SH | SOLE | 9,312 | 0 | 0 | ||
CHARTER COMMUNICATIONS INC N | CL A | 16119P108 | 234 | 591 | SH | SOLE | 591 | 0 | 0 | ||
CREDIT ACCEP CORP MICH | COM | 225310101 | 232 | 479 | SH | SOLE | 479 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L601 | 279 | 324,452 | SH | SOLE | 324,452 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 244 | 15,487 | SH | SOLE | 15,487 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 656 | 61,875 | SH | SOLE | 61,875 | 0 | 0 | ||
EXPEDIA GROUP INC | COM NEW | 30212P303 | 216 | 1,622 | SH | SOLE | 1,622 | 0 | 0 | ||
FAR PT ACQUISITION CORP | COM CL A | 30734W109 | 260 | 25,509 | SH | SOLE | 25,509 | 0 | 0 | ||
FERROGLOBE PLC | SHS | G33856108 | 223 | 131,248 | SH | SOLE | 131,248 | 0 | 0 | ||
FS KKR CAPITAL CORP | COM | 302635107 | 242 | 40,548 | SH | SOLE | 40,548 | 0 | 0 | ||
GARRISON CAP INC | COM | 366554103 | 8,439 | 1,223,096 | SH | SOLE | 1,223,096 | 0 | 0 | ||
INTERACTIVE BROKERS GROUP IN | COM CL A | 45841N107 | 201 | 3,703 | SH | SOLE | 3,703 | 0 | 0 | ||
KALA PHARMACEUTICALS INC | COM | 483119103 | 9,597 | 1,504,272 | SH | SOLE | 1,504,272 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 540 | 27,402 | SH | SOLE | 27,402 | 0 | 0 | ||
MARKER THERAPEUTICS INC | COM | 57055L107 | 189 | 23,915 | SH | SOLE | 23,915 | 0 | 0 | ||
MASTERCARD INC | CL A | 57636Q104 | 236 | 892 | SH | SOLE | 892 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 5,254 | 2,101,533 | SH | SOLE | 2,101,533 | 0 | 0 | ||
MERCADOLIBRE INC | COM | 58733R102 | 280 | 457 | SH | SOLE | 457 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 13,562 | 1,624,241 | SH | SOLE | 1,624,241 | 0 | 0 | ||
MOODYS CORP | COM | 615369105 | 214 | 1,094 | SH | SOLE | 1,094 | 0 | 0 | ||
SCYNEXIS INC | COM | 811292101 | 5,666 | 4,325,000 | SH | SOLE | 4,325,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 4,105 | 14,010 | SH | SOLE | 14,010 | 0 | 0 | ||
SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 88 | 23,821 | SH | SOLE | 23,821 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 20,696 | 6,612,065 | SH | SOLE | 6,612,065 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 1,923 | 2,645,826 | SH | SOLE | 2,645,826 | 0 | 0 | ||
TRANSDIGM GROUP INC | COM | 893641100 | 232 | 479 | SH | SOLE | 479 | 0 | 0 | ||
UNITED CONTL HLDGS INC | COM | 910047109 | 225 | 2,566 | SH | SOLE | 2,566 | 0 | 0 | ||
VISA INC | COM CL A | 92826C839 | 238 | 1,370 | SH | SOLE | 1,370 | 0 | 0 |